TherapeuticsMD (TXMD) Appoints Hugh O’Dowd as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD (TXMD) Misses Q3 EPS by 1c
November 11, 2021 6:51 AM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $24.5 million versus the consensus estimate of $25.87 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More